Treatment Guidelines for Stage IV Non-Small Cell Lung Cancer Updated
New recommendations on the use of chemotherapy to treat people with Stage IV non-small cell lung cancer have been issued by the American Society of Clinical Oncology. The evidence-based clinical practice guideline indicates a person’s physical age should not determine the cancer treatment he or she is given. Instead, ASCO recommends oncologists take other factors into account, including physiological age and performance status, when determining appropriate treatment for people with Stage IV NSCLC.
♦ ♦ ♦ ♦ ♦
This article was originally published in Coping® with Cancer magazine, January/February 2010.